IL-5 Activators
The IL-5 activators encompass a diverse array of chemical entities that exert their influence through various signaling pathways and cellular processes. One notable group includes compounds such as Aclidinium Bromide, BAY 61-3606, and CC-292, which indirectly activate IL-5 by disrupting the M3 muscarinic acetylcholine receptor, B-cell receptor signaling, and Bruton's tyrosine kinase activity, respectively. These compounds demonstrate the interconnectedness of signaling networks, where modulation at one point can propagate effects throughout the cellular landscape, ultimately leading to IL-5 activation. Another subgroup, represented by CHIR-99021 and I-BET151, operates through interference with Wnt signaling and selective BET bromodomain inhibition, respectively. CHIR-99021 affects IL-5 activation by perturbing Wnt signaling and downstream events, while I-BET151 influences chromatin remodeling and gene expression, indirectly impacting IL-5 activation. These examples underscore the intricate interplay between cellular processes and IL-5 regulation.
Compounds like EHop-016, MLN8054, and PI-103 showcase the impact of targeting Rac GTPase, Aurora A kinase, and the PI3K/AKT/mTOR pathway, respectively. By modulating cytoskeletal dynamics, cell cycle progression, and PI3K signaling, these compounds indirectly influence IL-5 activation, highlighting the multifaceted nature of cellular pathways involved in IL-5 regulation. Purmorphamine and SB-431542 represent IL-5 activators acting through the Hedgehog and TGF-β signaling pathways, respectively. Purmorphamine influences IL-5 activation by inducing Hedgehog pathway activation and altering cellular differentiation dynamics. Conversely, SB-431542 disrupts IL-5 regulation by inhibiting the TGF-β type I receptor, thereby affecting downstream events related to TGF-β signaling. Finally, U0126 and R406 target the MAPK/ERK signaling pathway and Syk kinase, respectively, showcasing their impact on IL-5 activation through modulation of these crucial intracellular cascades. These IL-5 activators collectively demonstrate the intricate web of cellular processes and signaling pathways that can be harnessed to influence the activation of this specific target protein.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aclidinium Bromide | 320345-99-1 | sc-480200 | 100 mg | $388.00 | ||
Aclidinium Bromide inhibits the M3 muscarinic acetylcholine receptor, leading to reduced calcium mobilization. This inhibition disrupts the calcium-dependent signaling cascade, indirectly modulating IL-5 activation by affecting downstream pathways. | ||||||
BAY 61-3606 | sc-507485 | 2 mg | $345.00 | 1 | ||
BAY 61-3606 is a potent and selective inhibitor of Syk kinase, a crucial mediator in B-cell receptor signaling. By disrupting this signaling pathway, it indirectly influences IL-5 activation through the modulation of downstream cascades and cellular responses. | ||||||
Spebrutinib | 1202757-89-8 | sc-507524 | 100 mg | $375.00 | ||
Spebrutinib, also called AVL-292, is a Bruton's tyrosine kinase (BTK) inhibitor that interferes with B-cell receptor signaling. Through this mechanism, it indirectly impacts IL-5 activation by perturbing downstream signaling events and altering cellular responses. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR-99021 (GSK-3 Inhibitor XVI) is a glycogen synthase kinase-3 (GSK-3) inhibitor, affecting the Wnt signaling pathway. Its influence on Wnt signaling indirectly modulates IL-5 activation by altering downstream events within the cellular signaling network. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
EHop-016 inhibits Rac GTPase, a key regulator of cellular cytoskeletal dynamics. By affecting cytoskeletal rearrangements, this compound indirectly modulates IL-5 activation through the disruption of intracellular signaling and downstream events. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a selective BET bromodomain inhibitor, impacting gene transcription. Its influence on chromatin remodeling indirectly affects IL-5 activation by modulating the expression of genes involved in the regulation of relevant signaling pathways. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
MLN8054 is a potent Aurora A kinase inhibitor, disrupting cell cycle progression. Through its impact on cell cycle dynamics, it indirectly modulates IL-5 activation by altering the cellular environment and influencing downstream signaling pathways. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a dual PI3K/mTOR inhibitor, affecting the PI3K/AKT/mTOR signaling pathway. Its influence on this pathway indirectly modulates IL-5 activation by perturbing downstream events and cellular responses related to the PI3K pathway. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $57.00 $184.00 | 18 | |
Purmorphamine activates the Hedgehog signaling pathway, influencing cellular differentiation. Its impact on Hedgehog signaling indirectly modulates IL-5 activation by altering the cellular context and influencing downstream events within the signaling network. | ||||||
R406 | 841290-81-1 | sc-364595 sc-364595A | 2 mg 10 mg | $163.00 $377.00 | 16 | |
R406 is a Syk kinase inhibitor, disrupting B-cell receptor signaling. Through this mechanism, it indirectly influences IL-5 activation by perturbing downstream signaling events and altering cellular responses associated with Syk kinase activity. | ||||||